STUDI KARAKTERISTIK DAN PENGGUNAAN OBAT PADA PENDERITA HEPATITIS B DI RUMAH SAKIT PEMERINTAH KOTA MANADO PERIODE JANUARI 2011 – DESEMBER 2012

Authors

  • Lady zha-zha Luntungan
  • Fatimawali Fatimawali
  • Widdhi Bodhi

DOI:

https://doi.org/10.35799/pha.2.2013.2381

Abstract

ABSTRACT
Hepatitis B is a disease caused by the virus called hepatitis B wich characterized by an
inflammation that occurs in organs such as the liver. The transmission of Hepatitis B is higher
than the transmission of the HIV virus. This study aimed to investigate the characteristics and
use of the drug in hepatitis B patients in the Government Hospital in Manado. This research
is a descriptive study based on retrospective data collection for 2 years survey from January
2011 to December 2012. The respondent of this research involve of 70 patients with Hepatitis
B medical record. The results showed that based on group age, responden with age group 46-
65 has the highest percentage by 31 patients (44.3%), based on gender, males have the
highest percentage of total of 47 patients (67.1%), based on the duration of treatment, the
highest percentage is shown by the patient with 1 day threatment as 21 patients (30%). Based
on therapeutic treatment this research divided it into 2 kind of threatment. The first us single
agent therapy Hepamax consist of 27 patients (38.6%) The second therapy is combination
between Hepamax and Curcuma wich consist of 9 patients (12.9%). This research conducted
based on 100% oral route of medicine threatment.
Keywords: Hepatitis B, Hepatitis B medicine, Singel Therapy, Combination Therapy

Downloads

Published

2013-08-01

How to Cite

Luntungan, L. zha- zha, Fatimawali, F., & Bodhi, W. (2013). STUDI KARAKTERISTIK DAN PENGGUNAAN OBAT PADA PENDERITA HEPATITIS B DI RUMAH SAKIT PEMERINTAH KOTA MANADO PERIODE JANUARI 2011 – DESEMBER 2012. PHARMACON, 2(3). https://doi.org/10.35799/pha.2.2013.2381

Issue

Vol. 2 No. 3 (2013): pharmacon

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)